# Study to Assess the Effects of Intranasal Ketamine Along With rTMS for Patients With Treatment-resistant Major Depressive Disorder (TRD)

> **NCT04352621** · PHASE4 · UNKNOWN · sponsor: **University of Cincinnati** · enrollment: 20 (estimated)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** intranasal ketamine
- **DEVICE:** rTMS treatment

## Key facts

- **NCT ID:** NCT04352621
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-01
- **Primary completion:** 2022-05-01
- **Final completion:** 2022-05-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04352621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04352621, "Study to Assess the Effects of Intranasal Ketamine Along With rTMS for Patients With Treatment-resistant Major Depressive Disorder (TRD)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04352621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*